Tag: Stem Cell Research
With help from the zebrafish, a team of Australian researchers has uncovered how hematopoietic stem cells (HSC) renew themselves, considered by many to be the ‘holy grail’ of stem cell research.
HSCs are a significant type of stem cell present in the blood and bone marrow. These are needed for the replenishment of the body’s supply of blood and immune cells. HSCs already play a part in transplants in patients with blood cancers such as leukemia and myeloma. The stem cells are also studied for their potential to transform into vital cells including muscle, bone, and blood vessels.
THURSDAY, Aug. 7, 2014 (HealthDay News) — In a step toward using stem cells to treat paralysis, scientists were able to use cells from an elderly man’s skin to regrow nerve connections in rats with damaged spinal cords.
Reporting in the Aug. 7 online issue of Neuron, researchers say the human stem cells triggered the growth of numerous axons — the fibers that extend from the body of a neuron (nerve cell) to send electrical impulses to other cells.
(CNN) — Here’s a look at what you need to know about stem cells.
Scientists believe that stem cell research can be used to treat medical conditions including Parkinson’s Disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis.
NEWARK, Calif., May 29, 2014 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, posted today the following Letter to Shareholders from its President and CEO, Martin McGlynn.
“Why are we so excited about these findings and why should you be, too?”
San Diego, CA – A promising treatment for patients with spinal cord injuries and a therapy aimed at helping HIV patients create an AIDS-resistant blood system were approved today by the state’s stem cell agency, the California Institute for Regenerative Medicine (CIRM).
Both are part of the agency’s Strategic Partnership program, which aims to attract more industry investment in research projects funded by the stem cell agency, and accelerate the most promising projects into clinical trials. Both companies will match the funds that they are getting from the agency.
Scientists at the Research Institute for Stem Cell Research in Los Angeles have provided new hope in a breakthrough stem cell research paper published last Thursday. The new study documents the successful duplication of adult stem cells using the subject’s own DNA. The team, led by researcher Young Gie Chung, was able to turn skin cells extracted from an adult male into a hallow ovum, the ovum then multiplies and divides creating an embryo. While some scientists say the discovery is “not-earth-shattering,” others are more hopeful, saying nuclear transfer may be the first step in using stem cells ethically to cure degenerative diseases.
Crain’s Detroit Business is long overdue for a story or blog on Silly Putty. Better late than never, here we go:
As it turns out, a main component in silly putty helps stem cells that are being grown in culture turn into the specialized cells researchers need.
The component is called polydimethylsiloxane, and it provides a sponginess that aids stem-cell differentiation, according to a study by University of Michigan researchers published Sunday in the online journal Nature Materials.
The researchers coaxed human embryonic stem cells to turn into working spinal cord cells more efficiently by using a soft, ultrafine carpet of the silly stuff than by using other media.
LONDON, April 10, 2014 — Paralysis caused by a motor neuron disease or spinal cord injury understandably causes feelings of hopelessness, helplessness and despair. But there is optimism in a new technique that can artificially control paralyzed muscles using light.
The technique, developed at University College London and King’s College London could potentially restore the function of muscles afflicted by motor neuron disease or spinal cord injury.
Scientists have turned adult cells back to their embryonic form in under 30 minutes by simply treating them with acid in a breakthough which could revolutionise personalised medicine.
The era where organs and tissues can be re-grown is a step closer after scientists found treating adult cells with acid takes them back to an embryonic state in under 30 minutes.
Experts in the field of stem cells have hailed the research as groundbreaking and say, if replicated in humans, it would herald a new ‘age of personalised medicine.’
Philanthropist Denny Sanford is donating $100 million to UC San Diego to speed up attempts to turn discoveries about human stem cells into drugs and therapies to treat everything from cancer and Alzheimer’s disease to spinal-cord injuries and weak hearts.
The gift from the South Dakota businessman, who has a home in La Jolla, is the second largest in campus history — exceeded only by the $110 million donation that Qualcomm cofounder Irwin Jacobs contributed to help the University of California San Diego become a power in engineering. Sanford’s donation is also among the 15 largest gifts nationwide this year, and it pushes him past $1 billion in lifetime giving.